TTM Technologies, Inc. to Acquire Anaren, Inc. Broadens

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
701
TTM Technologies, Inc. to Acquire Anaren, Inc.

Broadens Product Portfolio, Adding Highly Engineered RF Components and Subsystems for Aerospace & Defense and Communications End Markets

Transaction Expected to be Accretive

COSTA MESA, Calif., Dec. 03, 2017 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ: TTMI ) (“TTM”) has agreed to acquire Anaren, Inc. (“Anaren”) for approximately $775 million in cash from affiliates of Veritas Capital.

The transaction combines TTM’s strength in printed circuit board (“PCB”) manufacturing with Anaren’s product portfolio of unique and proprietary radio frequency (“RF”) components and subsystems for the Aerospace & Defense and Networking/Communication end markets.  The combined company will be strongly positioned to benefit from the expected increased spending towards advanced radar technology in the Aerospace & Defense market and 5G technology in the wireless infrastructure market.

“TTM has had a long working relationship with Anaren, serving beside them on supplier councils, and has always been impressed with their RF engineering expertise,” said Tom Edman, CEO of TTM.  “We expect that integrating our manufacturing strength with Anaren’s RF engineering talent will enable us to deliver superior value-added solutions to our customers in Aerospace & Defense and our broader commercial markets.  We also believe that the combination will result in meaningful synergies created by complementary capabilities that will benefit the customers and employees of both companies.” 

“This is a compelling strategic combination that makes for an exciting new chapter for Anaren,” said Larry Sala, CEO of Anaren.  “We have admired TTM’s manufacturing strength for some time and believe this acquisition will accelerate the opportunities and potential for Anaren to grow its offerings.  This combination also positions TTM with industry leading high frequency electronics engineering and manufacturing capabilities to better meet our customer needs.  We are grateful for our partnership with Veritas over the past several years.  With Veritas’ support, we strengthened our market position and generated outstanding growth.”

Strategic Rationale

The acquisition of Anaren is expected to provide a number of benefits to TTM:

  • Broadens TTM’s product portfolio, adding highly engineered and differentiated RF products and contributes significant RF engineering talent.
  • Increases TTM’s capabilities in the Aerospace & Defense end market, enabling the company to rapidly develop value added solutions to better serve the U.S. Defense sector, and positioning the combined company for further long-term growth.
  • Provides new growth opportunity in the industrial, medical and automotive end markets.
  • Accretive to non-GAAP operating margins, adjusted EBITDA margins, non-GAAP EPS and free cash flow, providing a unique opportunity to achieve industry-leading financial performance, create significant value for customers and shareholders, and provide greater opportunities for employees.

Terms of the Transaction and Financial Highlights

Anaren, Inc. will be purchased in a debt free, cash free transaction for $775 million in cash, subject to working capital adjustments at closing. 

In the twelve months ended September 30, 2017, the combined company would have generated pro forma revenues of $2.8 billion and pro-forma adjusted EBITDA of $450 million.  For a reconciliation of pro-forma adjusted EBITDA to pro-forma GAAP net income, see Appendix A to TTM’s presentation filed as Exhibit 99.2 to TTM’s Current Report on Form 8-K filed on December 4th, 2017.

TTM has identified $15 million in pre-tax, run rate, cost synergies which are expected to be realized within the first two years after closing. TTM believes that significant additional synergies will result from other integration efforts over a longer period of time. This transaction is expected to be accretive to non-GAAP earnings.

TTM expects to finance the purchase with a $700 million add on to its existing Term Loan B and cash on hand.  In addition, TTM has received a fully-underwritten commitment from Barclays to finance the transaction. 

The transaction is subject to customary closing conditions, including regulatory approvals.  The transaction is expected to close in the first half of 2018.  Barclays acted as financial advisor for TTM, and Houlihan Lokey and Evercore acted as financial advisors for Anaren.  O’Melveny & Myers LLP acted as legal counsel for TTM.  Skadden, Arps, Slate, Meagher & Flom LLP acted as legal counsel for Anaren.

Investor Conference Call and Webcast

TTM will host a conference call on Monday, December 4th, 2017 at 8:30 AM Eastern Time to discuss the combination.  

Interested parties can listen to the conference call and view accompanying slides via webcast at www.ttmtech.com.  The call can also be accessed over the phone by dialing domestic 1-800-239-9838 or international 1-323-794-2551 (ID 9062905).

The replay of the webcast will remain accessible for one week following the live event on TTM’s website at www.ttmtech.com.

About TTM TTM Technologies, Inc. is a major global PCB manufacturer, focusing on quick-turn and volume production of technologically advanced PCBs and the backplane and sub-system assembly business. TTM stands for time-to-market, representing how TTM’s time-critical, one-stop manufacturing services enable customers to shorten the time required to develop new products and bring them to market. Additional information can be found at www.ttmtech.com.

About Anaren Anaren is a leading global designer and manufacturer of high-frequency RF and microwave microelectronics, components, and assemblies for the space, defense, and telecommunications sectors. Anaren's engineering expertise and products are utilized by major manufacturers around the world, in everything from telecommunications networking products, fighter-jet jammers, base-station amplifiers, to communication satellite systems. Anaren’s products are the result of innovative engineering, design, materials processing, and world-class volume manufacturing.

About Veritas Capital Veritas Capital is a leading private equity firm that invests in companies that provide critical products and services, primarily technology or technology-enabled solutions, to government and commercial clients worldwide, including those operating in aerospace & defense, healthcare, technology, national security, communications, government services, energy and education. Veritas Capital seeks to create value by strategically transforming the companies in which it invests through organic and inorganic means. For more information on Veritas Capital and its current and past investments, visit www.veritascapital.com.

Forward-Looking Statements This release contains forward-looking statements that relate to future events or performance. TTM cautions you that such statements are simply predictions and actual events or results may differ materially. These statements reflect TTM's current expectations, and TTM does not undertake to update or revise these forward looking statements, even if experience or future changes make it clear that any projected results expressed or implied in this or other TTM statements will not be realized. Further, these statements involve risks and uncertainties, many of which are beyond TTM's control, which could cause actual results to differ materially from the forward-looking statements. These forward-looking statements include statements related to: TTM’s ability to successfully complete the transaction on a timely basis, including receipt of required regulatory approvals and satisfaction of other conditions; the conditions of the credit markets and TTM’s ability to issue debt to fund the transaction on acceptable terms; if the transaction is completed, the ability to retain Anaren’s customers and employees, the ability to successfully integrate Anaren’s operations, product lines, technology and employees into TTM’s operations, and the ability to achieve the expected synergies as well as accretion in earnings; competitive pressures and consumer preferences in TTM’s various lines of business; unknown, underestimated or undisclosed commitments or liabilities; the potential impact of the announcement or consummation of the proposed transactions on the parties’ relationships with third parties, which may make it more difficult to maintain business and operational relationships; and potential changes in domestic or global economic conditions. For a description of additional factors that may cause TTM’s actual results, performance or expectations to differ from any forward-looking statements, please review the information set forth in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of TTM’s public reports filed with the SEC.

Use of Non-GAAP Financial Measures This release includes information about the combined company’s pro-forma adjusted EBITDA, which is a non-GAAP financial measure. TTM presents non-GAAP financial information to enable investors to see TTM through the eyes of management and to provide better insight into TTM’s ongoing financial performance. 

A material limitation associated with the use of the above non-GAAP financial measures is that they have no standardized measurement prescribed by GAAP and may not be comparable to similar non-GAAP financial measures used by other companies.  TTM compensates for these limitations by providing full disclosure of each non-GAAP financial measure and reconciliation to the most directly comparable GAAP financial measure.  However, the non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.

Contacts:

TTM Investors Sameer Desai, Senior Director, Corporate Development & Investor Relations Sameer.desai@ttmtech.com 714-327-3050

Anaren and Veritas Capital Andrew Cole/Patrick Scanlan Sard Verbinnen & Co 212-687-8080 veritascapital-svc@sardverb.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 0

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 95

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Africa Tech Festival Puts Trust Ahead of AI Hype Cycle

Updated Category News Views 11

Fifteen thousand people can fill a convention centre, but they cannot magically deliver a package, fund a small business, or repair harm from a bad automated decision. That rather useful dose of reality ran through the final day of Africa Tech Festival 2026 in Cape Town. The 29th edition drew more than 15,000 delegates across three days, and the strongest message was not...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 61

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading
Hope Charities Makes Care Funding Easier to Track Online

Updated Category News Views 72

A treatment bill can wreck a household long before a diagnosis does. That is the uncomfortable reality behind Hope Charities' new Access to Care website, a centralized resource meant to show people in the bleeding disorders community when diagnosis-specific charitable assistance funds are available. This is not flashy technology, nor should it be treated like some grand...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 18

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 0

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
BBW Lawsuit Puts Guidance and Walmart Claims Under Lens

Updated Category News Views 65

A three-month slice of 2026 has landed Build-A-Bear in the sort of mess investors hate most: a securities complaint centered on whether management's upbeat messaging had already outrun the facts. The lawsuit targets purchases of BBW shares from May 28, 2026 through August 26, 2026, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 66

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
Midea’s SC26 Cooling Pitch Targets AI Build Delays

Updated Category News Views 49

Heat is the uninvited partner in every AI build, and Midea is making a sensible argument that nobody gets paid for racks sitting idle while piping crews wrestle with a complicated cooling plant. At SC26 in Chicago, held November 17 through 19, the company made its North American debut for a modular prefabricated AI data-center cooling setup built around a magnetic coolant...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Labs Launches Innovative Open-Source Emissions Project

Updated Category News Views 204

Context Labs Introduces a Revolutionary Open Decarbonization Project Context Labs is set to make a significant impact in the world of emissions measurement with the launch of its Open Decarbonization Project (ODP). This initiative, in collaboration with key industry players, aims to foster transparency and reliability in carbon and methane emissions reporting using...

Continue Reading
BioAge Labs Exciting Participation in Key Investor Conferences

Updated Category News Views 124

BioAge Labs' Upcoming Investor Conferences BioAge Labs, Inc. (NASDAQ: BIOA), a dynamic player in the biotechnology sector, is ready to take significant strides in the world of investment discussions. This clinical-stage firm specializes in developing therapeutic products targeting metabolic diseases, particularly by exploring the biology of human aging. Engagements at...

Continue Reading
Tiba Biotech’s Revolutionary Vaccine Against Foot-and-Mouth Disease

Updated Category News Views 322

Introduction to Tiba Biotech's Innovative Vaccine Tiba Biotech is at the forefront of changing the landscape of animal health with its novel vaccine specifically designed to combat Foot and Mouth Disease (FMD). This innovative solution has emerged from an extensive challenge study evaluating its effectiveness in cattle, demonstrating that all vaccinated subjects...

Continue Reading
Santhera Pharmaceuticals Secures NICE Clearance for AGAMREE

Updated Category News Views 144

Santhera's Exciting New Journey with AGAMREE® Santhera Pharmaceuticals is making significant strides in the pharmaceutical industry with its innovative medication AGAMREE® (vamorolone), aimed at providing new hope for those affected by Duchenne muscular dystrophy (DMD). With the recent positive guidance from the National Institute for Health and Care Excellence (NICE),...

Continue Reading
Truelink Capital Invests in Horwitz MEP Expansion

Updated Category News Views 57

Truelink Forges New Path with Horwitz Partnership Private equity news always has a way of stirring the pot, and Truelink Capital's latest move is no exception. They announced a significant investment in Horwitz, a Minneapolis-based firm that's been dealing with mechanical, electrical, and plumbing (MEP) services for what seems like a century. Now, they’re digging in...

Continue Reading